Notice to Extend PAR-13-055 "Dissemination and Implementation Research in Health (R01)"

Notice Number: NOT-CA-16-006

Key Dates
Release Date: December 14, 2015

Related Announcements
PAR-13-055

Issued by
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH formerly NCCAM)
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute (NHGRI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Allergy and Infectious Diseases (NIAID) (Clarification per NOT-AI-13-034)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Mental Health (NIMH)
National Institute on Minority Health and Health Disparities (NIMHD)
National Institute of Nursing Research (NINR)
Office of Behavioral and Social Sciences Research (OBSSR)

Purpose

The purpose of this Notice is to extend PAR-13-055 "Dissemination and Implementation Research in Health (R01)", which encourages investigators to submit research grant applications that will identify, develop, evaluate and refine effective and efficient methods, systems, infrastructures, and strategies to disseminate and implement research-tested health behavior change interventions, evidence-based prevention, early detection, diagnostic, treatment and management, and quality of life improvement services, and data monitoring and surveillance reporting tools into public health and clinical practice settings that focus on patient outcomes.

The current expiration date is January 8, 2016. The new expiration date is May 10, 2016.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

David A. Chambers, D.Phil.
National Cancer Institute (NCI)
Telephone: 240-276-5090
Email: [email protected]